Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- The time to start putting some capital back into the market may be at hand, Jim Cramer told his Mad Money viewers Thursday after another roller-coaster day on Wall Street. Cramer said Friday's employment number might produce another selling panic, but there are now bargains to be had.
What should investors be looking for in the stocks they buy? Cramer said he's looking for companies that are primarily domestic, are buyers of the commodities that are falling in price and have earnings that are good or are getting better. He said investors also should pick companies that are now married to interest rates, are immune to a rising dollar and are new cyclical in nature.
What do the companies that fit this criteria look like? Restaurants fit the bill, with stocks like Darden Restaurants (DRI) - Get Report , Chipotle Mexican Grill (CMG) - Get Report and Domino's Pizza (DPZ) - Get Report all making Cramer's shopping list.
Then there are the high-growth names like Google (GOOGL) - Get Report , a stock which Cramer owns for his charitable trust, Action Alerts PLUS, along with Under Armour (UA) - Get Report and Facebook (FB) - Get Report , another Action Alerts PLUS holding.
Make no mistake, there may still be pain to come, Cramer concluded, but companies that fit these criteria can start being bought.
Don't Worry About the Saudis -- Yet
Is America's oil and gas renaissance in trouble now that Saudi Arabia has lowered the price of its oil for the fourth time in a row? Cramer said the decline in oil prices is indeed giving oil producers, and investors, the jitters, but it may not be time to panic just yet.
Cramer said it's clear that Saudi Arabia is driving the price of crude lower in an effort to keep the U.S. dependent on its oil by stifling the growth in our higher-cost shale fields. But even though it may feel like a bear market for oil, many of our independent oil and gas producers can still make money drilling at current prices, so the long-term oil and gas story remains intact.
But Cramer added that it would be naive to ignore the fact that eventually lower oil prices will start to impact production growth here in America. So while the long-term thesis may still be bullish, in the short term there may be more pain ahead as investors reset their expectations.
Drink Up Molson Coors
If there's one thing Cramer's learned over the years, it's that consolidation is great for stocks. So when the rumors started swirling that Anheuser-Busch InBev (BUD) - Get Report may be considering the acquisition of the London-based SABMiller, Cramer said he immediately determined that Molson Coors (TAP) - Get Report would be the big winner.
There are very few times in the stock market when investors can make money win, lose or draw, but a potential merger between the world's number one and number two beer makers would be one of them.
If InBev were to acquire SABMiller, Cramer said U.S. regulators would insist on certain divestitures, and the only logical beneficiary of those assets would be Molson Coors.
But what if SABMiller doesn't want to be acquired? Well, the logical countermeasure would be to acquire Molson Coors. Molson already has a partnership with SABMiller, so a defensive takeover would make perfect sense.
But even if no mergers take place, Cramer said that Molson Coors still makes for a terrific investment, as it's a solid consistent grower and one that's taking share all on its own.
Executive Decision: Dr. Ron Cohen
For his "Executive Decision" segment, Cramer sat down with Dr. Ron Cohen, president and CEO of Acorda Therapeutics (ACOR) - Get Report , a stock that's up 44% since Cramer first got behind the company in June 2012.
Acorda recently announced the $525 million acquisition of the privately held Civitas Therapeutics, a deal which gives Acorda access to new inhaled therapies for Parkinson's disease. Cohen said that while the FDA has been very critical of inhaled therapies, Civitas has been developing its methods for over 20 years, making him confident in the company's ability to complete a winning drug.
When asked why Civitas agreed to be acquired rather than complete an initial public offering, Cohen explained that Acorda had been watching Civitas for over 18 months. So when the company got close to its IPO roadshow, Acorda knew exactly what kind of deal would appeal to Civitas' investors.
Cramer said while he's been a fan of Acorda for quite some time, the acquisition of Civitas makes the company's outlook even better.
In the Lightning Round, Cramer was bullish on Ladenburg Thalmann Financial (LTS) - Get Report , Berkshire Hathaway (BRK.B) - Get Report , Intel (INTC) - Get Report , WhiteWave Foods (WWAV) , Lannett Company (LCI) - Get Report , Gilead Sciences (GILD) - Get Report and Celgene (CELG) - Get Report .
Off the Tape
In his "Off The Tape" segment, Cramer sat down with Dave Yarnold, CEO of the privately held ServiceMax, a cloud-based provider of field service management software.
Yarnold explained that his company provides the software to track everything a field service technician needs to do his or her job including schedules, inventory, equipment lists, service histories and more.
For a company like Pitney Bowes (PBI) - Get Report , Yarnold explained that ServiceMax was able to replace a heavily customized enterprise system with a cloud-based one that gave Pitney a more flexible and profitable mobile solution that just worked.
Cramer said while ServiceMax is not publicly traded, investors can benefit from knowing the latest trends and successes in the privately held world.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott Rutt
Follow Scott on Twitter
or get updates on Facebook,
At the time of publication, Cramer's Action Alerts PLUS had positions in FB, GOOGL, PVH and WAG.